Abstract
The development of new antimalarial compounds remains a pivotal part of the strategy for malaria elimination. Recent large-scale phenotypic screens have provided a wealth of potential starting points for hit-to-lead campaigns. One such public set is explored, employing an open source research mechanism in which all data and ideas were shared in real time, anyone was able to participate, and patents were not sought. One chemical subseries was found to exhibit oral activity but contained a labile ester that could not be replaced without loss of activity, and the original hit exhibited remarkable sensitivity to minor structural change. A second subseries displayed high potency, including activity within gametocyte and liver stage assays, but at the cost of low solubility. As an open source research project, unexplored avenues are clearly identified and may be explored further by the community; new findings may be cumulatively added to the present work.
Original language | English |
---|---|
Pages (from-to) | 687-701 |
Number of pages | 15 |
Journal | ACS Central Science |
Volume | 2 |
Issue number | 10 |
DOIs | |
State | Published - Oct 26 2016 |
Bibliographical note
Publisher Copyright:© 2016 American Chemical Society.
Funding
Medicines for Malaria Venture (MMV), the Australian Research Council (LP120100552, LP120200557), the Australian National Health and Medical Research Council (Project Grant 1042272). G.P. and J.P.O. were supported by EMBL Member States and MMV. The characterization by NMR spectroscopy of compounds from Lawrence University was made possible by the National Science Foundation (CHE- 0923473). C.S. was supported by Wellcome Trust Biomedical Resources Grant 099156/Z/12/Z.
Funders | Funder number |
---|---|
Wellcome Trust Biomedical Resources | 099156/Z/12/Z. |
National Science Foundation Arctic Social Science Program | CHE- 0923473 |
National Science Foundation Arctic Social Science Program | |
European Molecular Biology Laboratory | |
Australian Research Council | LP120200557, LP120100552 |
Australian Research Council | |
Australian National Health and Medical Research Council | 1042272 |
Australian National Health and Medical Research Council |
ASJC Scopus subject areas
- General Chemistry
- General Chemical Engineering